Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 known ✓ | P21453 | 1/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.48 |
| ▸ | FDPS | P14324 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL108550 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL1665720 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL9775488 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL10694855 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL10695022 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL6376295 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL8824219 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL6262112 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL9722909 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL2138964 | 1.00 | SMPD1 (0.48) | SMPD1FDPSDNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4270149-A | — | — | None | — | — | JP | disclosed |
| US-20260109817-A1 | FILM-FORMING ORGANOPOLYSILOXANE EMULSION COMPOSITION AND PRODUCTION METHOD THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4640786-A1 | WATER REPELLENT COMPOSITION AND FIBER TREATMENT AGENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4603554-A1 | EMULSION COMPOSITION OF FILM-FORMING ORGANOPOLYSILOXANE AND PRODUCTION METHOD THEREFOR | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-08-20 | — | — | EP | disclosed |
| CN-119998417-A | Emulsion composition of film-forming organopolysiloxane and method for producing same | 信越化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-114787282-B | Cationic emulsion composition of polyorganosiloxane and preparation method thereof | 信越化学工业株式会社 | 2024-12-03 | — | — | CN | disclosed |
| WO-2024135255-A1 | WATER REPELLENT COMPOSITION AND FIBER TREATMENT AGENT | 信越化学工業株式会社 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024080049-A1 | EMULSION COMPOSITION OF FILM-FORMING ORGANOPOLYSILOXANE AND PRODUCTION METHOD THEREFOR | 信越化学工業株式会社 | 2024-04-18 | — | — | WO | disclosed |
| CN-114787282-A | Cationic emulsion composition of polyorganosiloxane and preparation method thereof | 信越化学工业株式会社 | 2022-07-22 | — | — | CN | disclosed |
| WO-2021117508-A1 | CATIONIC EMULSION COMPOSITION OF POLYORGANOSILOXANE, AND METHOD FOR PRODUCING SAME | 信越化学工業株式会社 | 2021-06-17 | — | — | WO | disclosed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1217011-B1 | Process for producing an expoxidized polymer | KURARAY CO (JP) | 2005-10-12 | — | — | EP | disclosed |
| US-6541575-B2 | Epoxidation of polymer having olefinic carbon-carbon double in absence of alkali metal by adding aqueous solution of ammonium tungstate and/or tungstophosphoric acid and phosphoric acid, adding hydrogen peroxide and quternary ammonium salt | KURARAY CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20020082348-A1 | Process for producing an epoxidized polymer | KURARAY CO. LTD, (JP) | 2002-06-27 | — | — | US | disclosed |
| EP-1217011-A1 | Process for producing an expoxidized polymer | KURARAY CO., LTD. (JP) | 2002-06-26 | — | — | EP | disclosed |
| JP-H04270149-A | PRODUCTION OF LAMINATED GLASS | NIPPON SHOKUBAI CO LTD | 1992-09-25 | — | — | JP | disclosed |
| EP-0268261-A1 | Process for producing 1-hydrocarbyl mercaptans | PHILLIPS PETROLEUM COMPANY (US) | 1988-05-25 | — | — | EP | disclosed |
| US-3960762-A | Production of absorbents | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109817-A1 | FILM-FORMING ORGANOPOLYSILOXANE EMULSION COMPOSITION AND PRODUCTION METHOD THEREOF | COL2A1, COL1A1, SMCHD1 | S1PR1 213/4885SMPD1 704/4885FDPS 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.